Drug intelligence / Profile preview

quadrivalent virosomal influenza vaccine

Development stage
Unknown
Lead developer
Johnson & Johnson
Modality
Vaccines & Immunotherapeutics, Targeted Liposomes → Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intramuscular
01

Overview

Quadrivalent virosomal influenza vaccine is a type of influenza vaccine designed to provide active immunization against four different strains of the influenza virus—specifically, two influenza A subtypes and two lineages of influenza B. The "virosomal" formulation refers to the use of virosomes, which are lipid-based carriers incorporating viral proteins that mimic the natural structure of viruses but lack genetic material, thereby enhancing immune response without causing infection. Quadrivalent vaccines are updated annually based on predictions about circulating strains and aim to broaden protection compared to trivalent vaccines by including both major B lineages. The primary indication is prevention of seasonal influenza in various age groups[1][2][5]. Virosomal technology has been used in some licensed flu vaccines (e.g., Inflexal V), though most widely available quadrivalent flu vaccines use other platforms.

Other names
quadrivalent virosomal influenza vaccine
02

Targets

SA (Sialic acid)

Beyond the preview

Go deeper on quadrivalent virosomal influenza vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on quadrivalent virosomal influenza vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call